ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674085 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674085; 2) Community: the network communities that were significantly associated with the response to NSC 674085; 3) Molecule: the relationships between components within communities and NSC 674085; 4) MDR: the compounds that were significantly associated with the NSC 674085.

NSC Compound Enrichment Correlation
NSC 629749 .beta.-Lapachone 0.0123744972338281 0.095004681
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0123744972338281 0.18811552
NSC 637731 Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- 0.0123744972338281 0.19403098
NSC 648365 Insulin-Methotrexate conjugate 0.0123744972338281 0.25244492
NSC 657751 Null 0.0123744972338281 0.38167719
NSC 678102 4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-5-hydroxy-3,7-dimethoxy- 0.0133299224082802 -0.26842764
NSC 682429 2-(1-Propynyl)-3,17.beta.-estradiol 0.0133299224082802 0.13989831
NSC 690043 Null 0.0133299224082802 0.34115869
NSC 694698 Null 0.0133299224082802 0.34061406
NSC 695937 9-Acridinone, 1-[[[[(9-methoxy-5,11-dimethyl- 6H-pyrido[4,3-b]carbazol-1-yl)amino]-3-propyl(methyl) amino]-3-propyl]amino]-4-nitro-, dimethane sulfonate salt 0.0133299224082802 0.22839897
Total:79  Current:25    [First] [Prev] [Next] [Last]